nitroblue tetrazolium has been researched along with Myeloproliferative Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corberand, J; De Larrard, B; LaHarrague, P; Nguyen, F; Pris, J | 1 |
| Guseva, SA | 1 |
2 other study(ies) available for nitroblue tetrazolium and Myeloproliferative Disorders
| Article | Year |
|---|---|
Phagocytosis in myeloproliferative disorders.
Topics: Blood Bactericidal Activity; Cell Movement; Humans; Leukemia, Myeloid; Leukocytes; Myeloproliferative Disorders; Nitroblue Tetrazolium; Phagocytes; Phagocytosis; Polycythemia Vera; Primary Myelofibrosis; Thrombocytosis | 1980 |
[Evaluation of the phagocytosis disorders in myeloproliferative diseases based on data from the nitroblue tetrazolium reduction test].
Topics: Adolescent; Adult; Aged; Blood Donors; Escherichia coli; Female; Humans; Lipopolysaccharides; Male; Middle Aged; Myeloproliferative Disorders; Neutrophils; Nitroblue Tetrazolium; Oxidation-Reduction; Phagocytosis; Tetrazolium Salts | 1987 |